ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
116.36
-3.10 (-2.60%)
Sep 10, 2026, 12:44 PM EDT - Market open
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $10.25 billion as of September 10, 2026. Its market cap has increased by 53.31% in one year.
Market Cap
10.25B
Enterprise Value
9.72B
1-Year Change
53.31%
Ranking
Category
Stock Price
$116.36
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $10.25B, an increase of 4,446.33%. That is a compound annual growth rate of 40.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 10.25B | -6.83% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 11.36B |
| Axsome Therapeutics | 10.83B |
| Krystal Biotech | 10.60B |
| Cytokinetics | 10.11B |
| Praxis Precision Medicines | 9.82B |
| Kymera Therapeutics | 9.76B |
| Ionis Pharmaceuticals | 9.65B |
| Protagonist Therapeutics | 9.43B |